Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Maternal and perinatal outcomes in pregnancies with multiple sclerosis: a case-control study.
Progressive Loss of Retinal Ganglion Cells and Axons in Nonoptic Neuritis Eyes in Multiple Sclerosis: A Longitudinal Optical Coherence Tomography Study.
Oral Laquinimod for Multiple Sclerosis Treatment Significantly Reduced Disease Activity and Disability Progression While Providing Good Safety and Tolerability
Riluzole suppresses experimental autoimmune encephalomyelitis: implications for the treatment of multiple sclerosis.
Biogen Idec reports death of patient on its MS pill
Oligodendroglial membrane dynamics in relation to myelin biogenesis.
Genentech and Biogen Idec announce top-line results from a Phase II/III clinical trial of Rituxan in primary-progressive multiple sclerosis
199 Outcomes after microvascular decompression for patients with trigeminal neuralgia and suspected multiple sclerosis.
Myelin in cartilaginous fish.
Two endogenous retroviral loci appear to contribute to Multiple Sclerosis.
Combination therapy of interferon Beta-1b and tacrolimus: a pilot safety study.
More Than 15 Years of Experience with Intradetrusor OnabotulinumtoxinA Injections for Treating Refractory Neurogenic Detrusor Overactivity: Lessons to Be Learned.
Antioxidative enzymes activity and malondialdehyde concentration during mitoxantrone therapy in multiple sclerosis patients.
Mitoxantrone exerts both cytotoxic and immunoregulatory effects on activated microglial cells.
DNA strand breakage by peroxidase-activated mitoxantrone.
Neurovascular coupling in patients with relapsing-remitting multiple sclerosis.
Biogen Idec receives notification of PDUFA date extension for PLEGRIDY™ (peginterferon beta-1a)
Dysregulation of regulatory CD56(bright) NK cells/T cells interactions in multiple sclerosis.
Pathogenic implications of iron accumulation in multiple sclerosis.
Inhibition of dihydroorotate dehydrogenase by the immunosuppressive agent leflunomide.
Product Portfolio, Meda
Autoimmune AQP4 channelopathies and neuromyelitis optica spectrum disorders.
Synaptic pathology: a shared mechanism in neurological disease.
Randomized controlled trial of interferon- beta-1a in secondary progressive MS: Clinical results.
Vision Disturbances in Multiple Sclerosis.

Pages